Endari
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.endarirx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Endari
Emmaus Medical, Inc. specializes in the development and distribution of ENDARI, the first treatment for sickle cell disease in nearly two decades. ENDARI is indicated for adults and children aged 5 years and older to reduce the acute complications associated with sickle cell disease. The company provides support programs, copay assistance, and a specialty pharmacy locator to facilitate access to their product. Their primary clients include healthcare professionals and patients affected by sickle cell disease.Explore more
Popular SearchesEndariEmmaus Medical IncSIC Code 28,283NAICS Code 32,325Show moreEndari Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Endari your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Endari is spiking on competitors!
Endari, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Endari recently announced quarterly report
Funding: Get notified immidiatlly once Endari has new funding data
Product Launch: Get notified when Endari launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Endari had a recent Job posting/layoffs
Check if Endari has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Endari
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Endari
Compare insights from companies similar to Endari, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Endari is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Endari is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endari.
Endari Tech Stack
A closer look at the technologies used by Endari
See more technologies
Endari News & Media
Endari Raises $4M in Seed Funding
Endari, a San Francisco, CA-based cybersecurity company, raised $4M in seed funding. The backers were not disclosed. Led by CEO and Founder Nils Puhlmann, Endari empowers SMBs and startups with tailored cybersecurity solutions at every stage, enabling them to take action and move forward with confidence. Its cybersecurity maturity model offers scalable security solutions that grow […] The post Endari Raises $4M in Seed Funding appeared first on FinSMEs.Cybersecurity Industry Veteran Nils Puhlmann Launches Endari to Help SMBs and Startups Build Holistic Cybersecurity Programs and Achieve Cybersecurity Independence
SAN FRANCISCO--(BUSINESS WIRE)--Endari, a pioneering cybersecurity company, has today announced its official launch from stealth mode by Nils Puhlmann, a seasoned cybersecurity veteran with over 30 years of experience. The company has also raised $4M in seed funding led by investors who recognize the critical need for effective cybersecurity solutions in the startup ecosystem. With this funding, Endari has created a proprietary and comprehensive cybersecurity maturity model that has been testedEmmaus Life Sciences Receives Marketing Authorization for Puerto Rico
TORRANCE, Calif., Feb. 2, 2024 /PRNewswire-HISPANIC PR WIRE/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease (SCD) treatment, today announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari® (L-glutamine oral...Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease (SCD) treatment, today announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari® (L-glutamine oral powder). This...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Endari
Sign Up For FreeTo access detailed company insights
Emmaus Medical, Inc. specializes in the development and distribution of ENDARI, the first treatment for sickle cell disease in nearly two decades. ENDARI is indicated for adults and children aged 5 years and older to reduce the acute complications associated with sickle cell disease. The company provides support programs, copay assistance, and a sp... Read More
